3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
32
Myelodysplastic Syndromes
28
Multiple Myeloma
27
Precursor Cell Lymphoblastic Leukemia-Lymphoma
26
Hodgkin Disease
12
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
11
Lymphoma, Non-Hodgkin
10
Lymphoma
10
Hematologic Neoplasms
10
Neuroblastoma
9
Myeloproliferative Disorders
9
Anemia, Refractory, with Excess of Blasts
8
Lymphoma, Mantle-Cell
7
Leukemia, Myelomonocytic, Chronic
7
Leukemia
7
Neoplasms, Plasma Cell
6
Lymphoma, T-Cell
6
Leukemia, Biphenotypic, Acute
6
Graft vs Host Disease
6
Leukemia, Lymphocytic, Chronic, B-Cell
5
Burkitt Lymphoma
5
Recurrence
4
Primary Myelofibrosis
4
Melanoma
4
Lymphoma, Large B-Cell, Diffuse
4
Lymphoma, Follicular
4
Leukemia, Myelomonocytic, Juvenile
4
Hematologic Diseases
4
Ganglioneuroblastoma
4
Anemia, Aplastic
4
Interventions
Temozolomide
43
Magnetic Resonance Spectroscopy
41
Radiotherapy
22
Specimen Handling
18
Biopsy
13
X-Rays
10
Radiation
10
trametinib
8
Bevacizumab
8
Nivolumab
7
Blood Specimen Collection
7
olaparib
6
fluorodopa F 18
6
dabrafenib
6
Radiotherapy, Intensity-Modulated
6
Phantoms, Imaging
6
Nuclear Medicine Department, Hospital
6
Lomustine
6
pembrolizumab
5
abemaciclib
5
Standard of Care
5
vorasidenib
4
ulixertinib
4
larotrectinib
4
ivosidenib
4
erdafitinib
4
Surgical Procedures, Operative
4
Dianhydrogalactitol
4
Cyclophosphamide
4
Aminolevulinic Acid
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Glioma
×
Melphalan
×
1 year
×
Clear all
No trials found.